Increasing evidence points to a fundamental role for cancer stem cells (CSC) in the initiation and propagation of many tumors. As such, in the context of glioblastoma multiforme (GBM), the development of treatment strategies specifically targeted towards CSC-like populations may hold significant therapeutic promise. To this end, we now report that the cell surface chemokine receptor, CXCR4, a known mediator of cancer cell proliferation and invasion, is overexpressed in primary glioblastoma progenitor cells versus corresponding differentiated tumor cells. Furthermore, administration of CXCL1, the only known ligand for CXCR4, stimulates a specific and significant proliferative response in progenitors but not differentiated tumor cells. Taken together, these results implicate an important role for the CXCR4 signaling mechanism in glioma CSC biology and point to the therapeutic potential of targeting this pathway in patients with GBM. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
机构:
Barts & London Queen Marys Med Sch, Translat Oncol Lab, London EC1M 6BQ, EnglandBarts & London Queen Marys Med Sch, Translat Oncol Lab, London EC1M 6BQ, England
机构:
Univ Michigan, Sch Med, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USAUniv Michigan, Sch Med, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USA
机构:
Barts & London Queen Marys Med Sch, Translat Oncol Lab, London EC1M 6BQ, EnglandBarts & London Queen Marys Med Sch, Translat Oncol Lab, London EC1M 6BQ, England
机构:
Univ Michigan, Sch Med, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USAUniv Michigan, Sch Med, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USA